Study of Different Doses of a Novel Treatment for Onychomycosis
NCT00679965
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
159
Enrollment
INDUSTRY
Sponsor class
Conditions
Distal, Subungual Onychomycosis
Interventions
DRUG:
AN2690, 2.5%
DRUG:
AN2690, 5%
DRUG:
AN2690, 7.5%
DRUG:
AN2690 Solution Vehicle
Sponsor
Pfizer